Cholinergic Antagonists

Allergy and Allergic Diseases, Second Edition

Volumn 1, Issue , 2009, Pages 683-693

  Gross, Nicholas J ^a  

^a HINES VA HOSPITAL   (United States)

Author keywords

Adult asthma; Anticholinergic agent and its use in acute exacerbation management; Anticholinergic agents in stable childhood asthma; Cholinergic antagonists in respiratory disorder treatment; Dose response of anticholinergic agents and various inhalational methods; Muscarinic receptor subtypes in airways; Pediatric asthma; Protection against bronchospastic stimuli

Indexed keywords

EID: 74549199174     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300918.ch29     Document Type: Chapter

References (94)

1. Anthonisen, N.R., Connett, J.E., Kiley, J.P., Altose, M.D., Bailey, W.C. & Buist, A.S. (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272, 1497-505.
2. Ashutosh, K., Dev, G., Steele, D. (1995) Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease. CHEST 107, 173-78.
3. Ayala, L.E. & Ahmed, T. (1989) Is there loss of protective muscarinic receptor mechanism in asthma? Chest 96, 1285-91.
4. Ayala, L.E., Choudry, N.B. & Fuller, R.W. (1988) LTD4-induced bronchoconstriction in patients with asthma: lack of a vagal reflex. Br J Clin Pharmacol 26, 110-12.
5. Azevedo, M., da Costa, J.T., Fontes, P., da Silva J.P. & Araujo, O. (1990) Effect of terfenadine and ipratropium bromide on ultrasonically nebulized distilled water-induced asthma. J Int Med Res 18, 37-49.
6. Bateman, E.D., van Dyk, M. & Sagriotis, A. (2006) Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study. Pulm Pharmacol Ther E-Publication in advance of print. PMID:17118684.
7. Beck, R., Robertson, C., Galdes-Sebaldt, M. & Levison, H. (1985) Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. J Pediatr 107, 605-8.
8. Bleecker, E.R. & Britt, E.J. (1991) Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease. Am J Med 91(4A), 24S-27S.
9. Bollert, F.G., Matusiewicz, S.P., Dewar, M.H. et al. (1997) Comparative efficacy and potency of ipratropium via Turbuhaler and pressurized metered-dose inhaler in reversible airflow obstruction. Eur Respir J 10, 1824-8.
10. Braun, S.R., McKenzie, W.N., Copeland, C., Knight, L. & Ellersieck, M. (1989) A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med 149, 544-7. [Erratum appears in Arch Intern Med (1990) 150, 1242.].
11. Brophy, C., Ahmed, B., Bayston, S., Arnold, A., McGivern, D. & Greenstone, M. (1998) How long should Atrovent be given in acute asthma? Thorax 53, 363-7.
12. Brown, I.G., Chan, C.S., Kelly, C.A., Dent, A.G. & Zimmerman, P.V. (1984) Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation. Thorax 39, 272-6.
13. Casaburi, R., Mahler, D.A., Jones, P.W. et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19, 217-24.
14. Cazzola, M., Noschese, P., Salzillo, A., DeGiglio, C., D'Amato, G. & Matera, M.G. (2005) Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients. Respir Med 99, 524-8.
15. Celli, B.R. & MacNee, W. (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23, 932-46.
16. Celli, B., ZuWallack, R., Wang, S. et al. (2003) Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 124, 1743-8.
17. Chapman, K.R., Smith, D.L., Rebuck, A.S. & Leenen, F.H. (1985) Hemodynamic effects of inhaled ipratropium bromide, alone and combined with an inhaled beta 2-agonist. Am Rev Respir Dis 132, 845-7.
18. Combivent Inhalation Solution Study Group (1997) Routine nebulized ipratropium and albuterol together are better than either alone in COPD. Chest 112, 1514-21.
19. Coulson, F.R. & Fryer, A.D. (2003) Muscarinic acetylcholine receptors and airway diseases. Pharmacol Ther 98, 59-69.
20. Covelli, H., Bhattacharya, S., Cassino, C., Conoscenti, C. & Kesten, S. (2005) Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with COPD. Pharmacotherapy 25, 1708-18.
21. Decker, N., Quennedey, M.C., Rouot, B., Schwartz, J., Velly, J. (1982) Effects of N-aralkyl substitution of beta-agonists on alphaand beta-adrenoceptor subtypes: pharmacological studies and binding assays. J Pharm Pharmacol 34.
22. Disse, B., Reichl, R. & Speck, G. (1993) Ba 679 BR, a novel longacting anticholinergic bronchodilator. Life Sci 52, 537-44.
23. Donohue, J.F., van Noord, J.A., Bateman, E.D. et al. (2002) A 6-month, placebo controlled study comparing lung function and health status in COPD patients treated with tiotropium or salmeterol. Chest 122, 47-55.
24. Ducharme, F.M. & Davis, G.M. (1998) Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. J Pediatr 133, 479-85.
25. Dusser, D., Bravo, M.-L. & Iacono, P. (2005) The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur Respir J 27, 547-55.
26. Fryer, A.D. & Jacoby, D.B. (1991) Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 102, 267-71.
27. Fryer, A.D. & Jacoby, D.B. (1993) Effect of inflammatory cell mediators on M2 muscarinic receptors in the lungs. Life Sci 52, 529-36.
28. Gandevia, B. (1975) Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad Med J 51 (7 suppl.), 13-20.
29. GOLD Guidelines (2006) Available at www.goldcopd.com.
30. Gosens, R., Bos, I.S., Zaagsma, J. & Meurs, H. (2005) Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 171, 1096-102.
31. Grieco, M.H. & Pierson, R.N. Jr (1971) Mechanism of bronchoconstriction due to beta-adrenergic blockade. J Allergy Clin Immunol 48, 143-52.
32. Gross, N.J. (1986) COPD: a disease of reversible airways obstruction. Am Rev Respir Dis 133, 725-36.
33. Gross, N.J. (1988) Ipratropium bromide. N Engl J Med 319, 486-94.
34. Gross, N.J. (2004) Tiotropium bromide. Chest 126, 1946-53.
35. Gross, N.J. & Bankwala, Z. (1987) Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxaemic patients with chronic obstructive pulmonary disease. Comparison with a betaadrenergic agent. Am Rev Respir Dis 136, 1091-4.
36. Gross, N.J. & Barnes, P.J. (1988) A short tour around the muscarinic receptor. Am Rev Respir Dis 138, 765-7.
37. Gross, N.J. & Skorodin, S.M. (1984a) Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis 129, 856-70.
38. Gross, N.J. & Skorodin, M.S. (1984b) Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med 311, 421-5.
39. Gross, N.J. & Skorodin, M.S. (1985) Massive overdose of atropine methonitrate with only slight untoward effects [letter]. Lancet ii, 386.
40. Gross, N.J. & Skorodin, M. (1987) Anticholinergic agents. In: Jenne, J.W. & Murphy, S., eds. Drug Therapy of Asthma. Marcel Dekker, New York, pp. 615-68.
41. Gross, N.J., Co, E. & Skorodin, M.S. (1989a) Cholinergic bronchomotor tone in COPD: estimates of its amount in comparison with that in normal subjects. Chest 96, 984-7.
42. Gross, N.J., Petty, T.L., Friedman, M., Skorodin, M.S., Silvers, G.W. & Donohue, J.F. (1989b) Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Am Rev Respir Dis 139, 1188-91.
43. Gross, N., Tashkin, D., Miller, R., Oren, J., Coleman, W. & Linberg, S. (1998) Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group. Respiration 65, 354-62.
44. Gross, N.J., Paulson, D., Kennedy, D., Korducki, L. & Kesten, S. (2003) A comparison of maintenance tiotropium and salmeterol on arterial blood gas tensions in patients with COPD [Abstract]. Am Assn Respir Care 205, 234.
45. Hargreave, F.E., Dolovich, J. & Newhouse, M.T. (1990) The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 85, 1098-111.
46. Ikeda, A., Nishimura, K., Koyama, H. & Izumi, T. (1995) Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. Chest 107, 401-5.
47. Jolobe, O.M. (1984) Asthma vs. non-specific reversible airflow obstruction: clinical features and responsiveness to anticholinergic drugs. Respiration 45, 237-42.
48. Kanazawa, H. (2006) Anticholinergic agents in asthma, chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of remodeling. Curr Opin Pulm Med 12, 60-7.
49. Karpel, J.P., Pesin, J., Greenberg, D. & Gentry, E. (1990) A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. Chest 98, 835-9.
50. Kerstjens, H.A.M., Bantje, T.A., Luursma, P.B. et al. (2004) Tiotropium maintenance therapy and the additive effect of a single dose of ipratropium bromide or fenoterol in patients with COPD. Am J Respir Crit Care Med 169, A519.
51. Koutsogiannis, Z. & Kelly, A. (2000) Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department? Aust NZ J Med 30, 38-40.
52. Lefcoe, N.M., Toogood, J.H., Blennerhassett, G., Baskerville, J. & Paterson, N.A. (1982) The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis. A double-blind single dose study. Chest 82, 300-5.
53. Littner, M.R., Ilowite, J.S., Tashkin, D.P. et al. (2000) Long-acting bronchodilation with once-daily dosing of tiotropium in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161, 1136-42.
54. McFadden, E.R., Luparello, T., Lyons, H.A. & Bleeker, E. (1969) The mechanism of action of suggestion in the induction of acute asthma attacks. Psychosom Med 31, 134-43.
55. Maesen, F.P., Smeets, J.J., Sledsens, T.J., Wald, F.D. & Cornelissen, P.J. (1995) Tiotropium bromide, a new long-acting antimuscarinic bronchodilator:a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 8, 1506-13.
56. Mahler, D.A., Harver, A., Lentinet, T. et al. (1996) Descriptors of breathlessness in cardiorespiratory disease. Ann J Respir Crit Care Med 154, 1357-63.
57. Mak, J.C.W. & Barnes, P.J. (1990) Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis 141, 1559-68.
58. Maltais, F., Hamilton, A., Marciniuk, D. et al. (2005) Improvements in symptom-limited exercise performance with once-daily tiotropium in patients with COPD. Chest 128, 1168-78.
59. Martin, R.J., Bucher-Bartleson, B.L., Smith, P. et al. (1999) Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest 115, 1338-45.
60. Morganroth, J., Golisch, W. & Kesten, S. (2004) Electrocardiographic monitoring in COPD patients receiving tiotropium. COPD 1, 181-90.
61. Morr, H. (1979) Immunological release of histamine from human lung. II. Studies on acetylcholine and the anticholinergic agent ipratropium bromide. Respiration 38, 273-9.
62. Nadel, J.A. (1980) Autonomic regulation of airway smooth muscle. In: Nadel, J.A., ed. Physiology and Pharmacology of the Airways. Marcel Dekker, New York, pp. 217-57.
63. Niewoehner, D.E., Rice, K., Cote, C. et al. (2005) Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once daily inhaled anticholinergic bronchodilator. Ann Int Med 143, 317-26.
64. O'Donnell, D.E., Fluge, T., Gerken, F. et al. (2004) Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD. Eur Respir J 23, 832-40.
65. Passamonte, P.M. & Martinez, A.J. (1984) Effect of inhaled atropine or metaproterenol in patients with chronic airway obstruction and therapeutic serum theophylline levels. Chest 85, 610-15.
66. Patrick, D.M., Dales, R.E., Stark, R.M., Laliberte, G. & Dickinson, G. (1990) Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy. Chest 98, 295-7.
67. Pavia, D., Bateman, J.R., Sheahan, N.F. & Clarke, S.W. (1979) Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction. Thorax 34, 501-7.
68. Petty, T.L. (1994) In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alon. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group. Chest 105, 1411-19.
69. Plotnick, L. & Ducharme, F. (1998) Should inhaled anticholinergics be added to β2 agonists for treating acute childhood and adolescent asthma? A systematic review. BMJ 317, 971-7.
70. Qureshi, F., Pestian, J., Davis, P. & Zaritsky, A. (1998) Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 339, 1030-5.
71. Rebuck, A.S. & Marcus, H.I. (1979) Sch1000 in psychogenic asthma. Scand J Respir Dis 103 (suppl.), 186-90.
72. Rebuck, A.S., Chapman, K.R., Abboud, R., Pare P.D., Kreisman, H. & Wolkove, N. (1987) Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 82, 59-64.
73. Reisman, J., Galdes-Sebalt, M., Kazim, F., Canny, G. & Levison, H. (1988) Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children. J Allergy Clin Immunol 81, 16-20.
74. Richardson, J.B. (1982) The innervation of the lung. Eur J Respir Dis Suppl 117, 13-31.
75. Richter, K., Stenglein, S., Mucke, M. et al. (2006) Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD. Respiration 73, 414-19.
76. Ruffin, R.E., Fitzgerald, J.D. & Rebuck, A.S. (1977) A comparison of the bronchodilator activity of Sch 1000 and salbutamol. J Allergy Clin Immunol 59, 136-41.
77. Salpeter, S.R., Buckley, N.S., Salpeter, E.E. (2006) Meta-analysis: anticholinergics, but not beta-agonists, reduces severe exacerbations and respiratory mortality in COPD. J Gen Int Med 21, 1011-19.
78. Sato, K., Koyama, S., Okubo, Y. et al. (1998) Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol 274, L970-L979.
79. Schuh, S., Johnson, D.W., Callahan, S., Canny, G. & Levison, H. (1995) Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr 126, 639-45.
80. Shah, P.K., Lakhotia, M., Mehta, S., Jain, S.K. & Gupta, G.L. (1990) Clinical dysautonomia in patients with bronchial asthma. Study with seven autonomic function tests. Chest 98, 1408-13.
81. Stoodley, R.G., Aaron, S.D. & Dales, R.E. (1999) The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a meta-analysis of randomized clinical trials. Ann Emerg Med 34, 8-18.
82. Tashkin, D. & Kesten, S. (2003) Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses Chest 123, 1441-9.
83. Tashkin, D.P., Ashutosh, K., Bleecker, E.R., Britt, E.J., Cugell, D.W. & Cummiskey, J.M. (1986) Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study. Am J Med 81(5A), 81-90.
84. Thiessen, B. & Pedersen, O.F. (1982) Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide. Respiration 43, 304-16.
85. Tobin, M.J., Hughes, J.A. & Hutchison, D.C. (1984) Effects of ipratropium bromide and fenoterol aerosols on exercise tolerance. Eur J Respir Dis 65, 441-6.
86. Ullah, M.I., Newman, G.B. & Saunders, K.B. (1981) Influence of age on response to ipratropium and salbutamol in asthma. Thorax 36, 523-9.
87. Van Noord, J.A., Smeets, J.J., Custers, F.L. et al. (2002) Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. Eur Respir Dis 19, 639-44.
88. Van Noord, J.A., Aumann, J.L., Janssens, E. et al. (2006) Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 129, 509-17.
89. Vichyanond, P., Sladek, W.A., Sur, S., Hill, M.R., Szefler, S.J. & Nelson, H.S. (1990) Efficacy of atropine methylnitrate alone and in combination with albuterol in children with asthma. Chest 98, 637-42.
90. Vincken, W., van Noord, J.A., Greenhorst, A.P. et al. (2002) Dutch/Belgian Tiotropium Study Group. Imroved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 19, 209-16.
91. Warner, J.O., Gotz, M., Landau, L.I., Levison, H., Milner, A.D. & Pedersen, S. (1989) Management of asthma: a consensus statement. Arch Dis Child 64, 1065-79.
92. Watson, W.T., Shuckett, E.P., Becker, A.B. & Simons, F.E. (1994) Effect of nebulized ipratropium bromide on intraocular pressures in children. Chest 105, 1439-41.
93. Widdicombe, J.G. (1979) The parasympathetic nervous system in airways disease. Scand J Respir Dis Suppl 103, 38-43.
94. Zorc, J.J., Pusic, M.V., Ogborn, C.J., Lebet, R. & Duggan, A.K. (1999) Ipratropium bromide added to asthma treatment in the pediatric emergency department. Pediatrics 103, 748-52.